Fatal anaphylaxis in children in France: Analysis of national data

Pouessel, G.; Tanno, Luciana Kase; Claverie, Claire; Lejeune, Stéphanie; Labreuche, Julien; Dorkenoo, Aimée; Renaudin, Jean‐Marie; Eb, Mireille; Leteurtre, Stéphane; Deschildre, A.

doi:10.1111/pai.12828

Cited by 27 publications

(26 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Interestingly, the current issue hosts a further contribution on the management of allergic reactions in French schools . This contribution nicely pairs with earlier French epidemiologic data on anaphylaxis, providing valuable data from the communities . Further reports on either national US trends on emergency visits for anaphylaxis or circumstances of reaction shed further light into the epidemiology of anaphylaxis …”

supporting

confidence: 60%

“…Noriyuki Yanagida EDITORIAL valuable data from the communities. [17][18][19] Further reports on either national US trends on emergency visits for anaphylaxis or circumstances of reaction shed further light into the epidemiology of anaphylaxis. 20,21 We hope that the above-commented articles, as well as all other contributions in this issue, will arouse your interest.…”

Section: Ann-marie Malby Schoosmentioning

confidence: 99%

See 1 more Smart Citation

Fecal metabolites and early sensitization influence asthma, and how to prevent anaphylaxis in the community

Eigenmann

2019

Pediatric Allergy Immunology

View full text Add to dashboard Cite

supporting

confidence: 60%

Section: Ann-marie Malby Schoosmentioning

confidence: 99%

Fecal metabolites and early sensitization influence asthma, and how to prevent anaphylaxis in the community

Eigenmann

2019

Pediatric Allergy Immunology

View full text Add to dashboard Cite

“…While a previous Korean NHI data analysis reported that the subtypes of anaphylaxis were in order of unspecified (83%), food (10%), drug (6.6%), and serum (0.4%) based on ICD codes [ 19 ], hospital-based case studies revealed that drugs and foods were the most common triggers of anaphylaxis in Korean adults and children, respectively [ 9 , 10 ]. Similarly, the disparity between a national data analysis and hospital-based case studies was also observed in other regions such as Europe [ 22 , 23 ]. The population-based national data analysis has the advantage of being able to analyze parameters such as prevalence; however, it has a disadvantage in that reliable analysis of the detailed factors of anaphylaxis, such as triggers and symptoms, is rather difficult.…”

Section: Discussionmentioning

confidence: 87%

A population-based epidemiological study of anaphylaxis using national big data in Korea: trends in age-specific prevalence and epinephrine use in 2010–2014

Jeong

Lee

Kang

et al. 2018

Allergy Asthma Clin Immunol

View full text Add to dashboard Cite

BackgroundPrevious reports on anaphylaxis in Asia are limited to relatively small-scale studies. We performed this study to identify the nationwide prevalence of anaphylaxis and epinephrine prescription rates by age groups.MethodsThe total number of patients, yearly and overall prevalence, percentage of emergency department visits, and epinephrine prescription rates were calculated for patients diagnosed with anaphylaxis based on the Korean National Health Insurance database from 2010 to 2014.ResultsThe mean prevalence of anaphylaxis in Korea was 26.23 (95% confidence interval, CI 25.78–26.68) per 100,000 person-years during the 5 years. It increased from 20.55 (95% CI 20.15–20.10) in 2010 to 35.33 (95% CI 34.81–35.85) per 100,000 person-years in 2014. The average prevalence was > 35 per 100,000 person-years among 50–69 year-olds, and the mean crude prevalence in children was 22.3 (0–2 years), 17.3 (3–6 years), 12.1 (7–12 years), and 14.9 (13–17 years) per 100,000 person-years, respectively. The overall prevalence increased 1.7-fold, with the highest rate of increase in 0–2 years of age. The overall percentage of emergent anaphylaxis patients was 88.4%, and the prevalence of emergent anaphylaxis increased from 18.63 (95% CI 18.25–19.01) to 31.28 (95% CI 30.79–31.77) per 100,000 person-years. In-hospital epinephrine prescription rate increased from 31.5 to 39.7%.ConclusionsThe mean prevalence of anaphylaxis in Korea was 26.2 per 100,000 person-years during the study period. The total number of anaphylaxis patients increased 1.7-fold from 2010 to 2014, with the most noticeable increment being in young children.

show abstract

“…In the case of anaphylaxis, however, there are only a limited number of population-based epidemiologic studies of mortality, particularly in the case of lowand middle-income countries. [15][16][17][18][19][20][21][22][23][24][25] Underrecognition and undernotification of anaphylaxis led to sparse data and contributed to lack of recognition of the importance of anaphylaxis and the consequent neglect of health care strategies for improving diagnosis, treatment, and prevention at many levels of the health care system.…”

Section: Anaphylaxis: Undernotification Of a Killing Hypersensitivitymentioning

confidence: 99%

Changing the history of anaphylaxis mortality statistics through the World Health Organization's International Classification of Diseases–11

Tanno

Chalmers

Bierrenbach

et al. 2019

Journal of Allergy and Clinical Immunology

View full text Add to dashboard Cite

We review the history of the classification and coding changes for anaphylaxis and provide current and perspective information in the field. In 2012, an analysis of Brazilian data demonstrated undernotification of anaphylaxis-related deaths because of the difficulties of coding using the International Classification of Diseases, 10th Revision. This work triggered strategic international actions supported by the Joint Allergy Academies and the International Classification of Diseases World Health Organization (WHO) leadership to update the classification of allergic disorders for the International Classification of Diseases, 11th Revision (ICD-11), which resulted in construction of the pioneer ''Allergic and hypersensitivity conditions'' chapter. The usability of the new framework has been tested by evaluating the same data published in 2012 from the ICD-11 perspective. Coding accuracy was much improved, reaching 95% for definite anaphylaxis. As the results were provided to the WHO Mortality Reference Group, coding rules have been changed, allowing anaphylaxis to be recorded as an underlying cause of death in official mortality statistics. The mandatory use of ICD-11 from January 2022 for documenting cause of death could have 2 immediate consequences: (1) the reported number of

show abstract

Fatal anaphylaxis in children in France: Analysis of national data

Abstract: Emails : avb.rodehorst@gmx.de and Filipiak-Pittroff@t-online

Cited by 27 publications

References 12 publications

Fecal metabolites and early sensitization influence asthma, and how to prevent anaphylaxis in the community

Fecal metabolites and early sensitization influence asthma, and how to prevent anaphylaxis in the community

A population-based epidemiological study of anaphylaxis using national big data in Korea: trends in age-specific prevalence and epinephrine use in 2010–2014

Changing the history of anaphylaxis mortality statistics through the World Health Organization's International Classification of Diseases–11

Contact Info

Product

Resources

About